CHRONOPHARMACOKINETICS OF CYCLOSPORINE-A IN THE WISTAR RAT FOLLOWING ORAL-ADMINISTRATION

被引:14
作者
MALMARY, MF [1 ]
KABBAJ, K [1 ]
LABAT, C [1 ]
BATALLA, A [1 ]
HOUTI, I [1 ]
MOUSSAMIH, S [1 ]
OUSTRIN, J [1 ]
机构
[1] UNIV HASSAN 2,FAC SCI,CASABLANCA,MOROCCO
关键词
CHRONOPHARMACOKINETICS; CYCLOSPORINE-A; ORAL ADMINISTRATION; RADIOIMMUNOASSAY; COMPARTMENT-DEPENDENT OR INDEPENDENT APPROACHES;
D O I
10.1007/BF03188782
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The pharmacokinetics of Cyclosporine A (CsA) was studied in male Wistar rats weighing 300 +/- 50 g trained to a 12:12 light-dark cycle. Oral administration (40 mg/kg) was performed at 1 of 4 different temporal stages: 09.00 h, 15.00 h, 21.00 h or 03.00 h (local time) i.e. 0200, 0800, 1400 or 2000 HALO (hours after light on). Blood samples were collected over 72-96 h after dosing, plasma was separated by centrifugation at 37-degrees-C and stored frozen until assay, using radioimmunoassay (RIA). Two experiments were performed: the first with 4 groups of 48 rats and a non-specific polyclonal antibody (P-RIA); and the second with only 2 groups of 48 rats and a more specific monoclonal antibody (M-RIA). Plasma concentration data were evaluated with model-based linear pharmacokinetic concepts, with apparent zero-order or first-order absorption and n-exponential disposition (n = 1, 2 or 3) : models MN0 or MN1. A compartment-independent approach was also conducted and led to area under the plasma concentration-time curve (AUC) and mean residence time (MRT) determinations. A comparison of the pharmacokinetic profiles across time of administration indicates that absorption, first-pass metabolism and tissue distribution of CsA in the rat are circadian-dosing stage dependent.
引用
收藏
页码:135 / 144
页数:10
相关论文
共 38 条
[1]  
AKAGI H, 1991, J INT MED RES, V19, P1
[2]  
BELANGER PM, 1988, CHRONOPHARMACOLOGY, V5, P219
[3]  
Belanger PM., 1987, ANN REV CHRONOPHARMA, V4, P1
[4]  
BOWERS LD, 1986, TRANSPLANT P, V18, P137
[5]  
CANAFAX DM, 1988, TRANSPLANT P, V20, P471
[6]  
CANAFAX DM, 1988, ANN REV CHRONOPHARMA, V5, P5
[7]  
Feuers RJ, 1988, ANN REV CHRONOPHARMA, V4, P209
[8]  
Gibaldi Perrier, 1982, PHARMACOKINETICS, Vsecond
[9]   AREA-UNDER-THE-CURVE MONITORING OF CYCLOSPORINE THERAPY - PERFORMANCE OF DIFFERENT ASSAY-METHODS AND THEIR TARGET CONCENTRATIONS [J].
GREVEL, J ;
NAPOLI, KL ;
GIBBONS, S ;
KAHAN, BD .
THERAPEUTIC DRUG MONITORING, 1990, 12 (01) :8-15
[10]   PHARMACOKINETICS OF ORAL CYCLOSPORINE-A (SANDIMMUN) IN HEALTHY-SUBJECTS [J].
GREVEL, J ;
NUESCH, E ;
ABISCH, E ;
KUTZ, K .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 31 (02) :211-216